상세 보기
Phase IB-II combination neoadjuvant chemotherapy with docetaxel plus atezolizumab plus herceptin SC and pertuzumab (TAHP) for patients with HER2-positive early breast cancer and subsequent atezolizumab plus herceptin SC and pertuzumab (AHP) adjuvant therapy after surgery (Neo-PATH)
- Ahn, Hee Kyung;
- Kim, Ji-Yeon;
- Suh, Koung Jin;
- Kim, Gun Min;
- Sim, Sung Hoon;
- 외 4명
Citations
WEB OF SCIENCE
0- 제목
- Phase IB-II combination neoadjuvant chemotherapy with docetaxel plus atezolizumab plus herceptin SC and pertuzumab (TAHP) for patients with HER2-positive early breast cancer and subsequent atezolizumab plus herceptin SC and pertuzumab (AHP) adjuvant therapy after surgery (Neo-PATH)
- 저자
- Ahn, Hee Kyung; Kim, Ji-Yeon; Suh, Koung Jin; Kim, Gun Min; Sim, Sung Hoon; Lee, Ki Hyeong; Jung, Kyung Hae; Im, Seok-Ah; Park, Yeon Hee
- 발행일
- 2020-02
- 유형
- Meeting Abstract
- 저널명
- Cancer Research
- 권
- 80
- 호
- 4